SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-010540
Filing Date
2021-08-05
Accepted
2021-08-05 16:08:46
Documents
93
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q irwd-20210630x10q.htm   iXBRL 10-Q 2366506
2 EX-31.1 irwd-20210630xex31d1.htm EX-31.1 16765
3 EX-31.2 irwd-20210630xex31d2.htm EX-31.2 16822
4 EX-32.1 irwd-20210630xex32d1.htm EX-32.1 8009
5 EX-32.2 irwd-20210630xex32d2.htm EX-32.2 8011
  Complete submission text file 0001558370-21-010540.txt   9824264

Data Files

Seq Description Document Type Size
6 EX-101.SCH irwd-20210630.xsd EX-101.SCH 70118
7 EX-101.CAL irwd-20210630_cal.xml EX-101.CAL 70831
8 EX-101.DEF irwd-20210630_def.xml EX-101.DEF 326464
9 EX-101.LAB irwd-20210630_lab.xml EX-101.LAB 536790
10 EX-101.PRE irwd-20210630_pre.xml EX-101.PRE 513982
11 EXTRACTED XBRL INSTANCE DOCUMENT irwd-20210630x10q_htm.xml XML 1816368
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34620 | Film No.: 211148211
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences